Ann‐Katrin Schild

704 total citations
16 papers, 162 citations indexed

About

Ann‐Katrin Schild is a scholar working on Psychiatry and Mental health, Clinical Psychology and Neurology. According to data from OpenAlex, Ann‐Katrin Schild has authored 16 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 5 papers in Neurology. Recurrent topics in Ann‐Katrin Schild's work include Dementia and Cognitive Impairment Research (10 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 and Mental Health (4 papers). Ann‐Katrin Schild is often cited by papers focused on Dementia and Cognitive Impairment Research (10 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 and Mental Health (4 papers). Ann‐Katrin Schild collaborates with scholars based in Germany, United Kingdom and France. Ann‐Katrin Schild's co-authors include Frank Jessen, Yasemin Goereci, Finja Schweitzer, Christiana Franke, Clemens Warnke, Dix Meiberth, Franziska Maier, Oezguer A. Onur, Harald Prüß and Kim Klein and has published in prestigious journals such as Scientific Reports, Brain Behavior and Immunity and Journal of Alzheimer s Disease.

In The Last Decade

Ann‐Katrin Schild

14 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann‐Katrin Schild Germany 6 106 52 49 34 27 16 162
Debora Pain Italy 9 142 1.3× 29 0.6× 57 1.2× 42 1.2× 26 1.0× 21 200
Clément Gouraud France 7 102 1.0× 48 0.9× 70 1.4× 21 0.6× 12 0.4× 16 160
Moshgan Amiri Denmark 9 105 1.0× 64 1.2× 39 0.8× 29 0.9× 10 0.4× 15 201
Enrique Zaldívar Spain 5 132 1.2× 13 0.3× 101 2.1× 60 1.8× 12 0.4× 10 254
Ignacio Cancela‐Cilleruelo Spain 10 236 2.2× 83 1.6× 97 2.0× 58 1.7× 17 0.6× 18 311
Marco Michelutti Italy 5 107 1.0× 35 0.7× 27 0.6× 38 1.1× 38 1.4× 11 143
Greta García‐Escobar Spain 6 33 0.3× 54 1.0× 38 0.8× 11 0.3× 17 0.6× 11 131
Maria Rita Reitano Italy 6 232 2.2× 40 0.8× 155 3.2× 119 3.5× 50 1.9× 11 310
Francesco Bax Italy 7 73 0.7× 32 0.6× 16 0.3× 17 0.5× 12 0.4× 20 142
K Zeiler Canada 9 46 0.4× 121 2.3× 17 0.3× 19 0.6× 17 0.6× 17 268

Countries citing papers authored by Ann‐Katrin Schild

Since Specialization
Citations

This map shows the geographic impact of Ann‐Katrin Schild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Katrin Schild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Katrin Schild more than expected).

Fields of papers citing papers by Ann‐Katrin Schild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Katrin Schild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Katrin Schild. The network helps show where Ann‐Katrin Schild may publish in the future.

Co-authorship network of co-authors of Ann‐Katrin Schild

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Katrin Schild. A scholar is included among the top collaborators of Ann‐Katrin Schild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Katrin Schild. Ann‐Katrin Schild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Goereci, Yasemin, Finja Schweitzer, Carsten Finke, et al.. (2024). Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage. Scientific Reports. 14(1). 5326–5326. 5 indexed citations
3.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2024). Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome. European Archives of Psychiatry and Clinical Neuroscience. 274(8). 1945–1957. 5 indexed citations
4.
Rostamzadeh, Ayda, Vanessa Romotzky, Maitée Rosende‐Roca, et al.. (2024). Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project. Alzheimer s & Dementia. 20(11). 7635–7656. 1 indexed citations
5.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2023). Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome. Zeitschrift für Neuropsychologie. 34(2). 99–110. 13 indexed citations
6.
Franke, Christiana, Yasemin Goereci, Finja Schweitzer, et al.. (2023). Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behavior and Immunity. 109. 139–143. 49 indexed citations
7.
Schild, Ann‐Katrin, Dix Meiberth, Ingo Frommann, et al.. (2023). Neuropsychologische Demenzdiagnostik: Umfrage zum klinischen Standardvorgehen im Rahmen des Deutschen Netzwerks Gedächtnisambulanzen e. V.. Zeitschrift für Neuropsychologie. 34(4). 183–202. 2 indexed citations
8.
Schild, Ann‐Katrin, Dix Meiberth, Ayda Rostamzadeh, et al.. (2022). Alzheimer’s Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients. Dementia and Geriatric Cognitive Disorders. 51(2). 182–192. 23 indexed citations
9.
Schild, Ann‐Katrin, Yasemin Goereci, Kim Klein, et al.. (2022). Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort. Journal of Neurology. 270(3). 1215–1223. 37 indexed citations
10.
Schild, Ann‐Katrin, et al.. (2021). Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type. Journal of Alzheimer s Disease. 83(3). 1173–1186. 5 indexed citations
12.
Ourry, Valentin, Natalie L. Marchant, Ann‐Katrin Schild, et al.. (2020). Between‐country harmonization and differences of the Lifetime of Experiences Questionnaire (LEQ) for lifespan complex mental activity assessment. Alzheimer s & Dementia. 16(S6). 1 indexed citations
13.
Demnitz‐King, Harriet, Tim Whitfield, Marco Schlosser, et al.. (2020). Reflective pondering is associated with a global cognitive marker of Alzheimer’s disease risk. Alzheimer s & Dementia. 16(S6).
14.
Wesselman, Linda M.P., Ann‐Katrin Schild, Astrid M. Hooghiemstra, et al.. (2020). Targeting Lifestyle Behavior to Improve Brain Health: User-Experiences of an Online Program for Individuals with Subjective Cognitive Decline. The Journal of Prevention of Alzheimer s Disease. 7(3). 184–194. 5 indexed citations
15.
Meiberth, Dix, Xiaochen Hu, Ann‐Katrin Schild, et al.. (2020). Decreased cortical thickness in individuals with subjective cognitive decline with and without CSF‐AD‐pathology: Data from the DELCODE Study. Alzheimer s & Dementia. 16(S5). 1 indexed citations
16.
Wesselman, Linda M.P., Ann‐Katrin Schild, Nina Coll‐Padrós, et al.. (2018). Wishes and preferences for an online lifestyle program for brain health—A mixed methods study. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 141–149. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026